We are delighted to welcome Johnson&Johnson as the newest Core Member of the SiLA Consortium.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/innovativemedicine/
We believe open standards are key to unlocking the full potential of laboratory automation. They enable seamless integration, foster innovation across the ecosystem, and significantly reduce the risks and costs associated with deploying advanced automation solutions. By joining the SiLA Consortium, we are proud to contribute to a growing community dedicated to interoperability and digital transformation, helping to accelerate the realization of next-generation automated laboratories and data-driven scientific discovery.
